Crossmark

A retrospective Case-Control study investigating the association of XPC Lys939Gln (rs2228001), XPD Lys751Gln (rs13181), and TP53 Arg72Pro (rs1042522) with papillary thyroid carcinoma susceptibility in the Bangladeshi population

Crossref DOI link: https://doi.org/10.1007/s11033-025-11305-5

Published Online: 2025-11-27

Published Print: 2026-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jahan Bristy, Nowshin

Islam, Md. Ariful

Noor, Al-Rownoka

Islam, MM Towhidul

Kabir, Yearul
License Information

Text and Data Mining valid from 2025-11-27

Version of Record valid from 2025-11-27
More Information

Article History

Received: 19 October 2025

Accepted: 20 November 2025

First Online: 27 November 2025

Declarations

:

: The authors declare that no financial interests or personal connections could have influenced the research presented in this paper.

: The study received approval from the Ethical Review Committee of the Department of Biochemistry and Molecular Biology at the University of Dhaka. Ethical approval for this study was obtained under Ref. No. 155Biol.Scs. (November 27, 2021).

Document is current

Any future updates will be listed below